Arrhythmic effects of Ivabradine in patients with coronary artery disease

Clinical and Investigative Medicine

Volumn 32, Issue 5, 2009, Pages

  Murat, Sani N ^a   Orcan, Salih ^a   Akdemir, Ramazan ^a   Dogan, Mehmet ^a   Kara, Emel ^a   Balci, Mustafa ^a  

^a Diskapi Yildirim Beyazit Educational and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IVABRADINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MALE; P WAVE; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; BENZAZEPINES; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED;

EID: 70350221970     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Camm AJ, Lau CP. Electrophysiological effects of a single intravenous administration of ivabradine(S 16257) in adult patients with normal baseline electro-physiology. Drugs R D. 2003;4:83-89
2. Zhang R, Haverich A, Strüber M, Simon A, Pichlmaier M, Bara C. Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia. Clin Res Cardiol 2008;97:811-819
3. Chaitman BR, Sano J. Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease. Clin Cardiol. 2007;30:I25-30. (Pubitemid 46272012)
4. Milliez P, Messaoudi S, Nehme J, Rodriguez C, Samuel JL, Delcayre C. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure. Am J Physiol Heart Circ Physiol. 2009;296:H435-41.
5. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R; BEAUTIFUL Investigators: Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 372:807-816
6. McLaughlin NB, Campbell RWF, Murray A. Accuracy for automatic QT measurement techniques in cardiac patients and healthy persons. Heart 1996;76:422. (Pubitemid 26390799)
7. Sulfi S, Timmis AD. Ivabradine, the first selective sinus node I(f) channel inhibitor in the treatment of stable angina. Int J Clin Prac 2006;60:222-228 (Pubitemid 43740503)
8. Elming H, Holm E, Jun L, et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998;19:1391. (Pubitemid 28427142)
9. Whitsel EA, Raghunathan TE, Pearce RM , et al. RR interval variation, the Q-T interval index and risk of primary cardiac arrest among patients without clinically recognized heart disease. Eur Heart J 2001;22:65.
10. Gang Y, Guo XH, Crook R, Hnatkova K, Camm AJ, Malik M. Computerized measurements of QT dispersion in healthy subjects. Heart 1998;80:459 (Pubitemid 28535532)
11. Macfarlane PW. Measurement of QT dispersion. Heart 1998;80:421.
12. Higham PD, Campbell RWF. QT dispersion. Br Heart J 1994;71:508.
13. Krahn AD, Nguyen-Ho P, Klein GJ, Yee R, Skanes AC, Suskin N. QT dispersion: an electrocardiographic derivative of QT prolongation. Am Heart J 2001;141:111
14. Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990;63:342.
15. Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733-738 (Pubitemid 28237295)
16. Gialafos JE, Dilaveris PE, Gialafos EJ, et al. P dispersion: a valuable electrocardiographic marker for the prediction of paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol 1999;4:39
17. Yilmaz R, Demirbag R. P-wave dispersion in patients with stable coronary artery disease and its relationship with severity of the disease. J Electrocardiol 2005; 38:279-284 (Pubitemid 40898316)
18. Dilaveris PE, Andrikopoulos GK, Metaxas G , et al. Effects of ischemia on P wave dispersion and maximumP wave duration during spontaneous anginal episodes. Pacing Clin Electrophysiol 1999; 22:1640-1647
19. Dogan SM, Gursurer M, Aydin M, Kalaycioglu E, Cam F. P-wave duration and dispersion in patients with coronary slow flow and its relationship with TIMI Frame Count. Journal of Electrocardiology. J Electrocardiol. 2008;4:55-59
20. Pfisterer ME, Klöter-Weber UC, Huber M , et al. Selective versus nonselective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low dose sotalol. Eur Heart J 1998;19:794-800 (Pubitemid 28227165)
21. Roche F, Xuong AN, Court-Fortune I , et al. Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance. Pacing Clin Electrophysiol 2003;26:669-677 (Pubitemid 36399474)
22. Yilmaz R, Demirbag R, Durmus I , et al. Association of stage of left ventricular diastolic dysfunction with P-wave dispersion and occurrence of atrial fibrillation after first acute anterior myocardial infarction. Ann Noninvasive Electrocardiol 2004;9:330-338 (Pubitemid 39540332)